Document Detail

Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer.
MedLine Citation:
PMID:  18468403     Owner:  NLM     Status:  MEDLINE    
Early age at full-term pregnancy lowers the risk of breast cancer in women; lactation seems to be of marginal importance and aborted pregnancy is not associated with reduced risk. Although early full-term pregnancy provides protection against breast cancer, first full-term pregnancy in older women appears to increase the risk. The protective effect of pregnancy has also been observed in rats and mice; in these animals, lactation has an additive effect and interrupted pregnancy provides partial but significant protection. Pregnancy at a young age (< or = 3 months) is highly effective, but pregnancy in older animals (> or = 4 months) is less effective. Parity-induced protection against mammary cancer in rodents can be reproduced by short-term treatment (approximately equivalent to gestational period of rodent or shorter) with the pregnancy hormones, estrogen and progesterone. Administration of pregnancy hormones to nulliparous women may be a useful strategy for protection against breast cancer. However, estrogen and progesterone are thought to play major roles in promotion of the proliferation of breast epithelial cells. Thus, the duration of such treatment and the age at which it is administered are essential factors that require further study. Experimental data suggest that short-term treatment of older rats (aged 6 months) with estrogen and progesterone accelerates mammary carcinogenesis and that long-term (>20 weeks) treatment abolishes the cancer-suppressing effect or even accelerates mammary carcinogenesis. Thus, the available evidence suggests that age and duration of estrogen and progesterone treatment are particularly important factors for protection from breast cancer.
Airo Tsubura; Norihisa Uehara; Yoichiro Matsuoka; Katsuhiko Yoshizawa; Takashi Yuri
Related Documents :
8147233 - Human chorionic gonadotropin secretion from the early human placenta: in vitro regulati...
21225793 - Immunohistochemical analysis of aquaporins in the fetal and adult vocal fold.
12265363 - Effects of non-medicated and copper iuds on sperm migration.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  In vivo (Athens, Greece)     Volume:  22     ISSN:  0258-851X     ISO Abbreviation:  In Vivo     Publication Date:    2008 Mar-Apr
Date Detail:
Created Date:  2008-05-12     Completed Date:  2008-06-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8806809     Medline TA:  In Vivo     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  191-201     Citation Subset:  IM    
Department of Pathology II, Kansai Medical University, Moriguchi, Osaka 570-8506, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticarcinogenic Agents / therapeutic use*
Dose-Response Relationship, Drug
Estrogens / administration & dosage*
Mammary Glands, Animal / cytology,  drug effects*
Mammary Neoplasms, Experimental / chemically induced,  pathology,  prevention & control*
Progesterone / administration & dosage*
Treatment Outcome
Reg. No./Substance:
0/Anticarcinogenic Agents; 0/Estrogens; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Investigation of ABCA1 C69T and G-191C polymorphisms in coronary artery disease.
Next Document:  Development of foreign body giant cells in response to implantation of Spongostan as a scaffold for ...